Medicare Enrolled

Dr. Suman Pasupuleti, M.D,

Cardiovascular Disease · Inverness, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Speaking/Promotional
308 W HIGHLAND BLVD, Inverness, FL 34452
3527268353
In practice since 2007 (18 years)
NPI: 1851503809 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pasupuleti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pasupuleti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pasupuleti

Dr. Suman Pasupuleti is a cardiovascular disease in Inverness, FL, with 18 years in practice. Based on federal Medicare data, Dr. Pasupuleti performed 11,905 Medicare services across 5,887 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pasupuleti received a total of $79,501 from 42 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pasupuleti is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 5% volume in FL$ $79,501 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,905
Medicare services
Top 5% in FL for cardiovascular disease
5,887
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~661 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)2,290$91$254
Prothrombin time test (blood clotting)676$4$9
Remote pacemaker/defibrillator monitoring, 90 days676$16$43
Anticoagulant management of patient taking warfarin658$8$23
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec648$27$141
Regadenoson injection (Lexiscan) for heart stress test550$43$244
Hospital follow-up visit, moderate complexity532$62$160
Echocardiogram, transthoracic526$139$381
Remote pacemaker monitoring, 90 days506$21$60
Electrocardiogram (EKG), 12-lead490$10$29
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days340$19$52
Technetium tc-99m sestamibi, diagnostic, per study dose312$87$332
Evaluation of cardiac rhythm monitor system, remote up to 30 days311$20$53
Remote patient monitoring device, 30 days253$35$95
Remote patient monitoring management, 20 min/month238$35$96
Office visit, established patient (20-29 min)236$63$179
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician210$49$138
Initial hospital admission, moderate complexity200$103$263
Blood draw (venipuncture)194$8$17
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days175$27$73
Nuclear medicine studies of heart muscle at rest and with stress and spect156$330$846
New patient office visit (45-59 min)124$116$333
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes118$10$27
Evaluation of single, dual, multiple lead or leadless pacemaker system111$38$110
Hospital follow-up visit, high complexity110$93$240
Initial hospital admission, high complexity104$137$352
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries96$313$454
Office visit, established patient, complex (40-54 min)92$135$357
Basic metabolic blood panel84$8$17
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional83$49$141
Complete blood count (CBC) with differential64$8$16
Comprehensive metabolic blood panel55$10$21
Heart muscle strain imaging54$28$72
Nuclear medicine study of heart muscle blood flow by pet48$139$487
Insertion of pacemaker and upper and lower heart chamber electrode46$408$1,076
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional43$20$51
Lipid panel (cholesterol and triglycerides)38$13$27
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional38$627$1,601
Evaluation of single, dual, or multiple lead implantable defibrillator system38$52$144
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan34$2,094$5,345
Removal and replacement of dual lead permanent pacemaker29$275$732
Natriuretic peptide (heart and blood vessel protein) level26$38$79
Programming of dual lead pacemaker system26$58$156
Ultrasound of heart, follow-up26$70$191
Programming of multiple lead implantable defibrillator system25$75$209
External shock to heart to regulate heart beat22$82$221
Ultrasound of heart with probe in esophagus, with report22$83$211
Ultrasound of heart blood flow, valves and chambers22$14$35
Ultrasound of heart with color-depicted blood flow, rate and valve function22$2$6
Insertion of implantable defibrillator system19$710$1,895
Magnesium level test16$7$14
Nuclear medicine studies of blood flow in heart muscle at rest and with stress15$1,160$4,291
Ultrasound of both sides of head and neck blood flow15$135$372
Insertion of heart rhythm monitor under skin14$3,247$8,329
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment13$14$37
Insertion of left lower heart electrode for pacemaker or defibrillator12$380$969
Thyroid stimulating hormone (TSH) test12$16$34
New patient office visit (30-44 min)12$74$225
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.8% high complexity
9.5% medium
71.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$79,501
Total received (2018-2024)
Avg $11,357/year across 7 years
Top 6% in FL for cardiovascular disease
42
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,553 (81.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,910 (18.8%)
Other
Charitable contributions, space rental, and other categories
$38 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,206
2023
$5,410
2022
$2,966
2021
$7,307
2020
$9,006
2019
$25,482
2018
$25,125

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$34,896
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$20,405
Abbott Laboratories
$10,439
AstraZeneca Pharmaceuticals LP
$9,680
Medtronic, Inc.
$1,250
Novartis Pharmaceuticals Corporation
$243
Biosense Webster, Inc.
$240
Medtronic Vascular, Inc.
$224
PFIZER INC.
$223
Amgen Inc.
$221
Impulse Dynamics (USA) Inc.
$214
E.R. Squibb & Sons, L.L.C.
$165
TESARO, Inc.
$125
CHF Solutions, Inc
$113
Esperion Therapeutics, Inc.
$95
Boston Scientific Corporation
$84
Amarin Pharma Inc.
$84
Novo Nordisk Inc
$78
Merck Sharp & Dohme LLC
$72
Sunovion Pharmaceuticals Inc.
$59
Alnylam Pharmaceuticals Inc.
$52
ZOLL Circulation Inc
$52
Kestra Medical Technology Services, Inc.
$49
SANOFI-AVENTIS U.S. LLC
$49
Bardy Diagnostics, Inc.
$40
Welch Allyn
$38
Inari Medical, Inc.
$29
Teleflex LLC
$29
BOSTON SCIENTIFIC CORPORATION
$28
BIOTRONIK INC.
$28
Lexicon Pharmaceuticals, Inc.
$22
GENZYME CORPORATION
$21
Regeneron Healthcare Solutions, Inc.
$19
United Therapeutics Corporation
$19
Lundbeck LLC
$17
Nuwellis, Inc.
$17
Arrow International, Inc.
$17
Astellas Pharma US Inc
$16
CARDIVA MEDICAL, INC.
$16
AtriCure, Inc.
$15
CVRx, Inc.
$13
Janssen Scientific Affairs, LLC
$6
Top 3 companies account for 82.7% of total payments
Associated products mentioned in payments ›
3F · AQUADEX SMARTFLOW CONSOLE · ATTAIN COMMAND + SUREVALVE · AZURE XT DR MRI SURESCAN · Aquadex · Assure WCD · Assurity Pacemaker · Attain · Azure · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · CROME DR MRI SURESCAN · Cardiac Mapping System · CardioMEMS HF System · Cardiovascular- Research only · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · Claria MRI · Confirm Rx · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · Ellipse ICD · EnSite Velocity System Expansion Modules · Ensite Cardiac Mapping System · FABRAZYME · FARXIGA · FLOWTRIEVER CATHETER · Fortify Assura · HeartMate 3 Left Ventricular Dev · Interventional Products · JOT DX · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LifeVest · MICRA · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · None · ONPATTRO · OPTIMIZER · ORENITRAM · Optimizer · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · REVEAL LINQ · Radial Access - VascBand · Repatha · Resolute · Reveal LINQ · S · SELECTSECURE · SPRINT QUATTRO SECURE S MRI SURESCAN · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRAPLINER · TactiCath Quartz CFA Catheter · Temperature Management System · Tendril Pacing Lead · Utibron · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · WATCHMAN · WATCHMAN FLX · XARELTO · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for cardiovascular disease in FL.

Equivalent to $668 per 100 Medicare services performed
Looking for a cardiovascular disease in Inverness?
Compare cardiovascular diseases in the Inverness area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
18
Per 100K population
11.3
County median income
$55,355
Nearest hospital
HCA FLORIDA CITRUS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pasupuleti is a remote & electrophysiology specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (speaking/promotional, top 6%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pasupuleti experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pasupuleti performed 2,290 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pasupuleti receive payments from pharmaceutical companies?
Yes. Dr. Pasupuleti received a total of $79,501 from 42 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pasupuleti's costs compare to other cardiovascular diseases in Inverness?
Dr. Pasupuleti's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pasupuleti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →